Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis.

× No keyword cloud information.

34 in total

1. Variation and adaptation of Pseudomonas aeruginosa toxicity to HeLa cells and fibroblasts.

Authors: H Müller; C Kettelhack; M Kettelhack; H G Sonntag; G Keilich; R Brossmer; J Richards; V Kinzel; E Bäuerlein; H Pech
Journal: J Clin Microbiol Date: 1986-09 Impact factor: 5.948

Review 2. Cystic fibrosis. Infection and immunity to Staphylococcus aureus and Haemophilus influenzae.

Authors: D P Greenberg; H R Stutman
Journal: Clin Rev Allergy Date: 1991 Spring-Summer

Review 3. Clinical significance of Staphylococcus aureus in cystic fibrosis.

Authors: M I Marks
Journal: Infection Date: 1990 Jan-Feb Impact factor: 3.553

Review 4. Drug treatment of pneumonia in the hospital. What are the choices?

Authors: M Aoun; J Klastersky
Journal: Drugs Date: 1991-12 Impact factor: 9.546

5. Azlocillin compared with carbenicillin in the treatment of bronchopulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis.

Authors: A Penketh; M E Hodson; H Gaya; J C Batten
Journal: Thorax Date: 1984-04 Impact factor: 9.139

6. Antipseudomonal therapy in cystic fibrosis: aztreonam and amikacin versus ceftazidime and amikacin administered intravenously followed by oral ciprofloxacin.

Authors: U B Schaad; J Wedgwood-Krucko; K Guenin; U Buehlmann; R Kraemer
Journal: Eur J Clin Microbiol Infect Dis Date: 1989-10 Impact factor: 3.267

Review 7. New perspectives in understanding and management of the respiratory disease in cystic fibrosis.

Authors: S Suter
Journal: Eur J Pediatr Date: 1994-03 Impact factor: 3.183

8. Correlation between activity of beta-lactam agents in vitro and bacteriological outcome in acute pulmonary exacerbations of cystic fibrosis.

Authors: J L Gaillard; P Cahen; C Delacourt; C Silly; M Le Bourgeois; C Coustère; J de Blic; G Lenoir; P Scheinmann
Journal: Eur J Clin Microbiol Infect Dis Date: 1995-04 Impact factor: 3.267

9. Pharmacokinetics of amikacin in cystic fibrosis: a study of bronchial diffusion.

Authors: E Autret; S Marchand; M Breteau; B Grenier
Journal: Eur J Clin Pharmacol Date: 1986 Impact factor: 2.953

10. Antistaphylococcal antibodies in cystic fibrosis.

Authors: B Strandvik; A Hollsing; R Möllby; M Granström
Journal: Infection Date: 1990 May-Jun Impact factor: 3.553